Back to search results
NCT07620171

Peer Recovery Support for Opioid Use Disorder Treatment Retention

Enrolling by Invitation
NAAges 18+InterventionalSupportive care
University of Pennsylvania
~15 participants
Updated 2026-06-02 on ClinicalTrials.gov
What's tested:Peer Support

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
OUD treatment retention
Measured over 180 days

Conditions

Opioid Use Disorder
Peer Recovery Supporters
Peer Recovery Coaching
Primary Care
Buprenorphine

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Rebecca A Harris, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Diagnosis of opioid use disorder (OUD)
Currently receiving or initiating buprenorphine treatment from a primary care physician
Able to communicate in English
Access to a phone
Able and willing to provide written informed consent

Exclusion

Acute suicidal ideation or intent
Active mania or psychotic episode
Significant cognitive impairment

What this trial measures

  • OUD treatment retention180 days

    Retention in OUD treatment measured as time in days from treatment initiation (buprenorphine induction) to dropout (unplanned treatment termination) or treatment completion over the 180-day study period.